Clinical Trial Detail

NCT ID NCT02692755
Title Palbociclib / Letrozole in African American Women With HR+ HER2- Breast Cancer (PALINA)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Georgetown University
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib + Letrozole

Age Groups: adult senior

Additional content available in CKB BOOST